Ciphergen Biosystems, Inc. will announce 2nd Quarter 2003 Earnings results, after market close on July 24, 2003, following by a Conference Call on Friday, July 25, 2003.Business Editors FREMONT, Calif.--(BUSINESS WIRE)--July 18, 2003 Ciphergen Biosystems, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CIPH CIPH Canadian Institute of Plumbing and Heating ), will announce 2nd Quarter 2003 earnings on July 24, 2003, after market close, followed by its Quarterly Conference Call to discuss second quarter results and 2003 outlook on Friday, July 25, 2003, at 11:00 a.m. Eastern Time (8 a.m. Pacific Daylight Time). This call is being webcast by CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network and can be accessed at Ciphergen's web site at www.ciphergen.com. The webcast will also be distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com). About Ciphergen Ciphergen develops, manufactures and markets a family of ProteinChip(R) Systems and services for clinical, research and process proteomics applications, as well as a broad range of bioseparations media for protein purification Protein purification is a series of processes intended to isolate a single type of protein from a complex mixture. Protein purification is vital for the characterisation of the function, structure and interactions of the protein of interest. through its BioSepra process chromatography division. ProteinChip Systems and Biomarker Discovery Biomarker discovery is the process by which biomarkers are discovered. It is a medical term. Many commonly used blood tests in medicine are biomarkers. The way that these tests have been found can be seen as biomarker discovery. Center(R) collaborative services enable protein discovery, profiling, characterization and assay development to provide researchers with predictive analysis capabilities and a better understanding of biological functions at the protein level. ProteinChip Systems are enabling tools in the emerging field of protein-based biology research, known as proteomics. Proteomics provides a direct approach to understanding the role of proteins in the biology of disease, monitoring disease progression and evaluating the therapeutic effects and side effects Side effects Effects of a proposed project on other parts of the firm. of drugs. Ciphergen believes proteomics will be a major focus of biological research by enhancing the understanding of gene function and the molecular basis of disease. Additional information about Ciphergen can be found at www.ciphergen.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion